James D Budge

Title: James D Budge: Innovator in Mammalian Expression Systems

Introduction

James D Budge is a notable inventor based in Canterbury, GB. He has made significant contributions to the field of biotechnology, particularly in the development of expression systems for mammalian cells. His innovative work has led to the creation of a patent that enhances the heterologous expression of nucleic acid sequences.

Latest Patents

James D Budge holds a patent for a mammalian expression system. This invention relates to an expression system designed for the heterologous expression of a nucleic acid sequence of interest in a mammalian cell. The system comprises several genetic entities, including a nucleic acid sequence encoding a functional Epstein Barr virus nuclear antigen 1 (EBNA-1) and a nucleic acid sequence encoding a functional nucleoside diphosphate kinase A (NDPK-A). Additionally, it includes the nucleic acid sequence of interest and the Epstein Barr virus OriP sequence, which is crucial for the expression process. This patent represents a significant advancement in the field of genetic engineering and molecular biology.

Career Highlights

James D Budge is currently associated with Lonza Biologics Plc, a leading company in the life sciences sector. His work at Lonza focuses on developing innovative solutions for biopharmaceutical manufacturing. His expertise in mammalian expression systems has positioned him as a key player in the biotechnology industry.

Collaborations

James has collaborated with notable colleagues, including Robert Young and Mark C Smales. These collaborations have further enriched his research and development efforts, leading to advancements in the field.

Conclusion

James D Budge's contributions to the field of biotechnology, particularly through his patent on mammalian expression systems, highlight his role as an innovator. His work continues to influence the development of biopharmaceuticals and genetic engineering.